News
11-09-2009, 06:11 AM
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone treatment is associated with increased rates of benign breast biopsies, and early and late stages of cancer.
More... (http://www.medicalnewstoday.com/articles/170265.php)
More... (http://www.medicalnewstoday.com/articles/170265.php)